Literature DB >> 26676640

[Posttraumatic endophthalmitis : Complication following severe eye injury].

C S Mayer1, D A Loos2.   

Abstract

BACKGROUND: Posttraumatic endophthalmitis is a rare but another extremely threatening complication for quality of vision, which has already been compromised by the trauma after perforating eye injuries. One of the substantial difficulties is the distinction between posttraumatic inflammation and development of a bacterial infection.
METHODS: In a hospital-based study 149 consecutive cases of perforating ocular trauma with open injuries to the eye within a 5-year period were retrospectively investigated. The study included assessment of the relationship between the severity of the injury and the risk of posttraumatic endophthalmitis using the ocular trauma score (OTS), the diagnosis, the therapeutic management and the prognosis concerning visual outcome 1 year after the posttraumatic endophthalmitis.
RESULTS: In this study posttraumatic endophthalmitis was observed in 8 out of 149 cases (5.4 %) after perforating ocular injuries. Severe injuries had a higher risk of this complication. In comparison to the clinical courses of non-postraumatic endophthalmitis, the visual outcome showed a tendency to be worse after an average of 18 ± 6 months (1.25 vs 1.0 logMAR). In all of the cases the posttraumatic endophthalmitis could be successfully treated with antibiotics and surgery and the already severely limited visual function due to the injury could at least be maintained in most cases. DISCUSSION: Due to the low case numbers statistical evidence of a clear benefit of treatment by a rapidly initiated and intensive individualized surgery following trauma and a pathogen-specific and operative therapy is not possible: nevertheless, such a comprehensive therapeutic approach to posttraumatic endophthalmitis is recommended.

Entities:  

Keywords:  Infection; Inflammation; Surgery; Trauma; Visual acuity

Mesh:

Substances:

Year:  2016        PMID: 26676640     DOI: 10.1007/s00347-015-0190-8

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  22 in total

Review 1.  Posttraumatic endophthalmitis.

Authors:  T A Meredith
Journal:  Arch Ophthalmol       Date:  1999-04

2.  [Endophthalmitis].

Authors:  W Behrens-Baumann
Journal:  Klin Monbl Augenheilkd       Date:  2008-11-17       Impact factor: 0.700

Review 3.  Endophthalmitis following open-globe injuries.

Authors:  Y Ahmed; A M Schimel; A Pathengay; M H Colyer; H W Flynn
Journal:  Eye (Lond)       Date:  2011-12-02       Impact factor: 3.775

Review 4.  Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions.

Authors:  Michelle C Callegan; Michael Engelbert; David W Parke; Bradley D Jett; Michael S Gilmore
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

5.  Post-traumatic endophthalmitis.

Authors:  Rohan W Essex; Qing Yi; Patrick G P Charles; Penelope J Allen
Journal:  Ophthalmology       Date:  2004-11       Impact factor: 12.079

6.  [Epidemiology of open globe injuries].

Authors:  C Framme; J Roider
Journal:  Klin Monbl Augenheilkd       Date:  1999-11       Impact factor: 0.700

7.  Posttraumatic endophthalmitis.

Authors:  G S Brinton; T M Topping; R A Hyndiuk; T M Aaberg; F H Reeser; G W Abrams
Journal:  Arch Ophthalmol       Date:  1984-04

8.  Posttraumatic endophthalmitis. Causative organisms, treatment, and prevention.

Authors:  D V Alfaro; D Roth; P E Liggett
Journal:  Retina       Date:  1994       Impact factor: 4.256

Review 9.  Paediatric post-traumatic endophthalmitis.

Authors:  D V Alfaro; D B Roth; R M Laughlin; M Goyal; P E Liggett
Journal:  Br J Ophthalmol       Date:  1995-10       Impact factor: 4.638

10.  Incidence and visual outcome of endophthalmitis associated with intraocular foreign bodies.

Authors:  Imtiaz A Chaudhry; Farrukh A Shamsi; Essam Al-Harthi; Abdulwahab Al-Theeb; Elsanusi Elzaridi; Fenwick C Riley
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-04-28       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.